[1] WHO. Coronavirus disease (COVID-19) situation dashboard [EB/OL]. (2020-04-05)[2020-04-05]. https://experience.arcgis. com/experience/685d0ace521648f8a5beeeee1b9125cd.
[2] 长江网. 九成以上新冠肺炎患者使用中医药治疗, 有效率超九成[EB/OL]. (2020-03-23)[2020-04-05]. http://www.cjrbapp.cjn.cn/toutiao/p/169144.html.
[3] 巴元明, 李晓东, 闵晓俊, 等. 湖北省中医院新型冠状病毒肺炎中医药防治方案(第三版)[J].湖北中医杂志,2020,42(2):7-8.
[4] 长江网. 用于治疗新冠肺炎, 省中医院“肺炎1号”“强力肺炎1号”医院制剂获批备案[EB/OL]. (2020-02-24)[2020-04-05]. http://www.cjrbapp.cjn.cn/p/163360.html.
[5] 周文霞, 程肖蕊, 张永祥. 网络药理学: 认识药物及发现药物的新理念[J]. 中国药理学与毒理学杂志, 2012, 26(1):4-9. doi:  10.3867/j.issn.1000-3002.2012.01.002
[6]

HOPKINS A L. Network pharmacology[J]. Nat Biotechnol,2007,25(10):1110-1111. doi:  10.1038/nbt1007-1110
[7] 陈海彬, 周红光, 李文婷, 等. 网络药理学: 中药复方作用机制研究新视角[J]. 中华中医药杂志, 2019, 34(7):2873-2876.
[8] 李玉洁, 张为佳, MAYUREE T, et al. “苦寒”方药性效解[J]. 中医杂志, 2014, 55(19):1630-1634.
[9] 祝寅淏, 王帅, 李瑶, 等. 黄酮类化合物药理作用的研究进展[J]. 吉林医药学院学报, 2018, 39(3):219-223.
[10] 龚金炎, 张英, 吴晓琴. 黄酮类化合物抗病毒活性的研究进展[J]. 中草药, 2008, 39(4):623-627. doi:  10.3321/j.issn:0253-2670.2008.04.048
[11]

NGUYEN T T, WOO H J, KANG H K, et al. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris[J]. Biotechnol Lett,2012,34(5):831-838. doi:  10.1007/s10529-011-0845-8
[12]

RYU Y B, JEONG H J, KIM J H, et al. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition[J]. Bioorg Med Chem,2010,18(22):7940-7947. doi:  10.1016/j.bmc.2010.09.035
[13]

LIN C W, TSAI F J, TSAI C H, et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds[J]. Antiviral Res,2005,68(1):36-42. doi:  10.1016/j.antiviral.2005.07.002
[14]

GRIFONI A, SIDNEY J, ZHANG Y, et al. A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2[J]. Cell Host Microbe,2020,27(4):671-680. doi:  10.1016/j.chom.2020.03.002
[15] 孔艺, 吴红卫, 陈永, 等. 基于网络药理学和分子对接探讨痰热清注射液治疗新型冠状病毒肺炎机制[J].中草药,2020, 51(7):1785-1794.
[16]

TAN Y J, FIELDING B C, GOH P Y, et al. Overexpression of 7a, a protein specifically encoded by the severe acute respirato-ry syndrome coronavirus, induces apoptosis via a caspase-dependent pathway[J]. J Virol,2004,78(24):14043-14047. doi:  10.1128/JVI.78.24.14043-14047.2004
[17]

ZHOU Y, FU B, ZHENG X, et al. Aberrant pathogenic GM-CSF+T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus[J/OL]. bioRxiv, https://doi.org/10.1101/2020.02.12.945576.
[18]

WONG C K, LAM C W, WU A K, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndro-me[J]. Clin Exp Immunol,2004,136(1):95-103. doi:  10.1111/j.1365-2249.2004.02415.x
[19]

HUANG C L, WANG Y M, LI X W, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet,2020,395(10223):497-506. doi:  10.1016/S0140-6736(20)30183-5
[20]

HODGE D R, HURT E M, FARRAR W L. The role of IL-6 and STAT3 in inflammation and cancer[J]. Eur J Cancer,2005,41(16):2502-2512. doi:  10.1016/j.ejca.2005.08.016